Abstract
Unavailable in the radiation armamentarium of modern day oncology are systemic and highly specific agents for selective radiation. Radiolabeled antibodies now offer both the specific selectivity as well as the opportunity for selective systemic irradiation which may be enhanced by appropriate chemotherapeutic integration.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Leichner, P. K., Klein, J. L., Garrison, J. B., Jenkins, R. E., Nickloff, E. L., Ettinger, D. S., Order, S. E.: Dosimetry of I–131 labeled antiferritin in hepatoma: A model for radioimmunoglobulin dosimetry. Int J Rad One Biol Phy (7): 323–333, 1981.
Ettinger, D. S., Order, S. E., Wharam, M. D., Parker, M. Klein, J. L., Leichner, P. K.: Phase I–II study of isotopic immunoglobulin therapy for primary liver cancer. Cancer Treat Rep. (66): 289–297, 1982.
Order, S. E.: Monoclonal antibodies: Potential role in radiation therapy and oncology. Int J Rad One Biol Phys (8): 1193–1201, 1982.
Wright, T., Sinanan, M., Harrington, D., Klein, J. L., Order, S.E.: Immunoglobulin: Applications to scanning and treatment Applied Rad (8) 120–124, 1979.
Maxon, H. R., Thomas, S. R., Hertzberg, V. S., Kereiakes, J. G., Chen, I. W. Sperling, M. I., Saenger, E. L.: Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. New Eng J Med (309) 937–941, 1983.
Order, S. E.: Radioimmunoglobulin therapy of cancer. Comprehensive Therapy (10): 9–18, 1984.
Shipley, W. U., Peacock, J. H., Steel, G. G., Stephens, T. C.: Continuous irradiation of the Lewis lung carcinoma in vivo at clinically used “ultra” low dose rates. Int J Rad One Biol Phys (9) 1647–1653, 1983.
Hilaris, B.S., Whitmore, W.F., Batata, M., Barzell, W.: Behavorial patterns of prostate adenocarcinoma following an 1–125 implant and pelvic lymphadenectomy. Int J Rad One Biol Phys (2) 631–637, 1977.
Feldman, G. B., Knapp, R. C., Order, S. E., Hellman, S.: The Role of lymphatic obstruction in the formation of ascites in a murine ovarian carcinoma. Cancer Res (32) 1663–1666, 1972.
Order, S. E., Donahue, V., Knapp, R.: Immunotherapy of ovarian carcinoma. An experimental model. Cancer (32) 573–579, 1973.
Suit, H., Order, S.E.: Considerations in the interactions of radiation and immunotherapy. In interaction of radiation and host immune defense mechanisms in malignancy. Brookhaven National Laboratory. New York, 1974, pp. 130–151.
Baker, L. H., Saiki, J. A., Jones, S.A.: Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: ASW one group study. Cancer Treat Rep (61): 1595–1598, 1977.
Sherman, D. M., Carabell, S.C., Belli, J. A., Hellman S.: The effect of dose rate and adriamycin on the tolerance of thoracic radiation in mice. Int J Rad One Biol Phys (8): 45–51, 1982.
Moertel, C. G., Childs, Jr., D. S., Reitemeier, R. J., Colby, Jr., M. Y., Holbrook, M. A.: Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. The Lancet: 865–867, 1969.
Machr J. P., Chatal, J.F., Lumbrosof S.D., Bacheggif F., Forni, M., Pitchard, J., Beiche, C., Douillard, J. Y., Carrelf S., Herlyn, M., Steplewski, Z, Koprowski, H.: Tumor localization in patients by radiolabelled monoclonal antibodies against colon carcinoma. Cancer Res (43) 5593–5600, 1983.
Epenetos, A. A., Britton, K. E., Mather, S., Sheperd, J., Granowska, M., Taylor-Papadimitriou, J., Nimmon C. C., Durbin, H., Hawkins, L. R., Malpas. J. S., Bodmer, W. F.: Targeting of iodine-123 labelled tumor-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumors. Lancet (6) 999–1005, 1982.
Rostock, R. A., Klein, J. L., Leichner, P. K., Kopher, K. A., Order, S.E.: Selective tumor localization in experimental hepatoma by radiolabeled antiferritin antibody. Int J Rad One Biol Phys (9) 1345–1350, 1983.
Rostock, R. A., Klein, J. L., Kopher, K. A., Order, S.E.: Variables affecting the tumor localization of I–131 antiferritin in experimental hepatoma. Amer J CI One (in press).
Order, S. E., Ettinger, D. S., Leibel, S. A., Klein, J. L., Leichner, P. K.: Cyclic radiolabeled I–131 antiferritin in multimodality therapy of hepatocellular carcinoma. Proc Amer Soc CI One (2) 119, 1983.
Lenhard, R. E., Order, S. E., Spunberg, J. J., Ettinger, D. S., Asbell, S. O., Leibel, S. A.: Radioimmunoglobulins: A new therapeutic modality in Hodgkin s disease. Proc Amer Soc CI One (2) 211, 1983.
Order, S. E., Klein, J. L., Ettinger, D., Alderson, P., Siegelman, S., Leichner, P.: Phase I–II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies. Int J Rad One Biol Phys (6): 703–710, 1980.
Order, S. E., Klein, J. L., Leichner, P. K., Wharam, M.D., Chambers, J., Kopher, K., Ettinger, D. S., Siegelman, S.S.: Radiolabeled antibodies in the treatment of primary liver malignancies. In: Levin, B. Riddel, R. (eds) Gastrointestinal Cancer. Elsevier North-Holland, New York (in press).
Kohler, G., Howe, S. C., Milstein, C.: Fusion between immunoglobulin-nonsecreting myeloma cell lines. Eur J Immunol (6) 292–295, 1976.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Order, S.E. (1984). The Use of Radiolabeled Antibody in Cancer Chemotherapy. In: Howell, S.B. (eds) Intra-Arterial and Intracavitary Cancer Chemotherapy. Developments in Oncology, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3843-7_23
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3843-7_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3845-1
Online ISBN: 978-1-4613-3843-7
eBook Packages: Springer Book Archive